ClinicalTrials.Veeva

Menu

Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine

J

Jaseng Hospital of Korean Medicine

Status

Completed

Conditions

Drug-Induced Liver Injury
Musculoskeletal Diseases

Treatments

Procedure: Pharmacopuncture
Drug: Herbal medicine
Procedure: Bee venom pharmacopuncture
Procedure: Acupuncture
Procedure: Chuna manipulation

Study type

Observational

Funder types

Other

Identifiers

NCT02299739
JS-CT-2013-02

Details and patient eligibility

About

Herb-induced liver injury is an important issue in musculoskeletal diseases where herbal medicine is most frequently used. The low prevalence of drug-induced liver injury (DILI) gives rise to the need for large-scale patient studies. We assessed the prevalence of liver injury of 6,894 musculoskeletal disease inpatients taking herbal medicine.

Full description

Herb-induced liver injury is an important issue in musculoskeletal diseases where herbal medicine is most frequently used. The low prevalence of drug-induced liver injury (DILI) gives rise to the need for large-scale patient studies. The objective of this study is to report on the incidence of liver injury from herbal medicine in musculoskeletal disease patients as large-scale studies are scarce.

Of 32,675 inpatients taking herbal medicine at 7 locations of a Korean medicine hospital between 2005 and 2013, we screened for liver injury in 6,894 patients with liver function tests (LFTs) at admission and discharge. LFTs included t-bilirubin, AST, ALT, and ALP. We assessed for risk factors for liver injury at discharge.

Participants received the most frequently used complementary and alternative medicine treatment contents (herbal medicine, acupuncture, pharmacopuncture, bee venom pharmacopuncture, and Chuna manipulation) administered to musculoskeletal disease patients at this hospital.

Enrollment

6,894 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients admitted for at least one day who took herbal medicine and at least 2 LFTs during admittance.

Exclusion criteria

  • None.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems